Gene · 84444
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the tail: the consequence of context in histone post-translational modification and chromatin research. | Biochem J | 2024 | 38353483 | PubTator, text mining | PubMed |
| Decoding the genetic symphony: Profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights. | PNAS Nexus | 2024 | 38328782 | PubTator, text mining | PubMed |
| Biological basis of extensive pleiotropy between blood traits and cancer risk. | Genome Med | 2024 | 38308367 | PubTator, text mining | PubMed |
| Development and validation of a cuproptosis-related prognostic model for acute myeloid leukemia patients using machine learning with stacking. | Sci Rep | 2024 | 38307903 | PubTator, text mining | PubMed |
| Micronucleus is not a potent inducer of the cGAS/STING pathway. | Life Sci Alliance | 2024 | 38307626 | PubTator, text mining | PubMed |
| Regulated cell death in glioma: promising targets for natural small-molecule compounds. | Front Oncol | 2024 | 38304870 | PubTator, text mining | PubMed |
| An epigenetic barrier sets the timing of human neuronal maturation. | Nature | 2024 | 38297124 | PubTator, text mining | PubMed |
| Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. | bioRxiv | 2024 | 38293113 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| Proline-directed yeast and human MAP kinases phosphorylate the Dot1p/DOT1L histone H3K79 methyltransferase. | FEBS J | 2024 | 38270553 | Swiss-Prot, curated | PubMed |
| Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. | Cell Transplant | 2024 | 38270130 | PubTator, text mining | PubMed |
| Role of Epigenetics for the Efficacy of Cisplatin. | Int J Mol Sci | 2024 | 38256203 | PubTator, text mining | PubMed |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | 38254219 | PubTator, text mining | PubMed |
| Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. | Cell Death Discov | 2024 | 38225241 | PubTator, text mining | PubMed |
| RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. | Genome Biol | 2024 | 38216972 | PubTator, text mining | PubMed |
| Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking. | Sci Rep | 2024 | 38200039 | PubTator, text mining | PubMed |
| MET fusions are targetable genomic variants in the treatment of advanced malignancies. | Cell Commun Signal | 2024 | 38195556 | PubTator, text mining | PubMed |
| The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. | Mol Biomed | 2024 | 38172378 | PubTator, text mining | PubMed |
| Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity. | Nat Commun | 2024 | 38167811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84444/papers?page=9